Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $576.38 | 14 | 90.0% |
| Education | $63.99 | 1 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $149.70 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.76 | 2 | $0 (2022) |
| Boston Scientific Corporation | $131.35 | 2 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $85.72 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $53.42 | 2 | $0 (2024) |
| Amgen Inc. | $49.26 | 2 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $28.16 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.01 | 7 | Actelion Pharmaceuticals US, Inc. ($85.72) |
| 2023 | $42.18 | 2 | Amgen Inc. ($21.97) |
| 2022 | $364.38 | 5 | Boston Scientific Corporation ($131.35) |
| 2021 | $16.80 | 1 | AstraZeneca Pharmaceuticals LP ($16.80) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | COUMADIN (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $63.99 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Cardiology | ||||||
| 04/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: Not Applicable | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $35.67 | General |
| Category: Cardiovascular | ||||||
| 12/15/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Cardiology | ||||||
| 09/11/2023 | PFIZER INC. | VYNDAQEL (Drug), COMIRNATY | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/08/2022 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $80.25 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/08/2022 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $51.10 | General |
| Category: General - Pain Management_NMD | ||||||
| 10/26/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $83.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 565 | 696 | $111,064 | $35,645 |
| 2022 | 3 | 699 | 786 | $142,615 | $45,353 |
| 2021 | 5 | 572 | 637 | $125,930 | $40,069 |
| 2020 | 5 | 260 | 286 | $66,780 | $19,118 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 316 | $74,892 | $25,602 | 34.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 32 | 128 | $9,472 | $6,058 | 64.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 45 | 45 | $13,005 | $2,030 | 15.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 187 | 192 | $13,440 | $1,842 | 13.7% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 15 | 15 | $255.00 | $114.57 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 411 | 478 | $120,012 | $41,903 | 34.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 277 | 296 | $20,210 | $2,966 | 14.7% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2022 | 11 | 12 | $2,393 | $484.07 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 318 | 362 | $99,550 | $33,779 | 33.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 204 | 220 | $14,300 | $2,385 | 16.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 18 | $5,400 | $1,776 | 32.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 21 | $4,200 | $1,294 | 30.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 16 | $2,480 | $834.40 | 33.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 124 | 141 | $38,775 | $11,303 | 29.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 17 | 19 | $11,400 | $3,413 | 29.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 17 | 17 | $7,225 | $2,314 | 32.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 90 | 92 | $5,980 | $1,169 | 19.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 17 | $3,400 | $917.55 | 27.0% |
About Amanda Uva, APRN
Amanda Uva, APRN is a Registered Nurse healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2018. The National Provider Identifier (NPI) number assigned to this provider is 1205312881.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Uva, APRN has received a total of $640.37 in payments from pharmaceutical and medical device companies, with $217.01 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($576.38).
As a Medicare-enrolled provider, Uva has provided services to 2,096 Medicare beneficiaries, totaling 2,405 services with total Medicare billing of $140,186. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Adult Health
- Location Hartford, CT
- Active Since 07/17/2018
- Last Updated 01/28/2020
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1205312881
Products in Payments
- VYNDAQEL (Drug) $149.70
- FARXIGA (Drug) $142.76
- OPSUMIT (Drug) $63.99
- Repatha (Biological) $49.26
- CAMZYOS (Drug) $35.67
- Arcalyst (Drug) $28.16
- UPTRAVI (Drug) $21.73
- COUMADIN (Drug) $17.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Hartford
Mrs. Agnes Arhin, Aprn, APRN
Registered Nurse — Payments: $1,455
Amber Newman
Registered Nurse — Payments: $1,053
Jeff Shaw
Registered Nurse — Payments: $516.08
Allison Osga, Aprn, APRN
Registered Nurse — Payments: $514.43
Sarah Rabbett, Aprn-Bc, APRN-BC
Registered Nurse — Payments: $380.46
Jonathan Pinter, Crna, CRNA
Registered Nurse — Payments: $354.03